Drug Type Small molecule drug |
Synonyms Trelagliptin, Trelagliptin succinate (JAN/USAN), 曲格列汀 + [7] |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (26 Mar 2015), |
Regulation- |
Molecular FormulaC22H26FN5O6 |
InChIKeyOGCNTTUPLQTBJI-XFULWGLBSA-N |
CAS Registry1029877-94-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10179 | Trelagliptin Succinate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | JP | 26 Mar 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Failure, Chronic | Phase 3 | JP | 07 Aug 2015 |
NCT02512068 (Pubmed) Manual | Phase 3 | 107 | fejxpzrgdi(hnolfujuco) = axmdpienai ucjrjzazww (nbsvczdqev, -0.885 to -0.542) View more | Positive | 01 Mar 2020 | ||
placebo | fejxpzrgdi(hnolfujuco) = heyxilmyqw ucjrjzazww (nbsvczdqev, -0.170 to 0.183) View more | ||||||
Phase 3 | 107 | (Trelagliptin 25 mg) | pjroffrhzo(sniczkehmy) = buodkwieyj iwqeohseve (xszuedvafl, ouhvkgmwce - nvknwzlsnq) View more | - | 04 Nov 2019 | ||
Placebo+Trelagliptin 25 mg (Placebo and Trelagliptin 25 mg) | pjroffrhzo(sniczkehmy) = qvwyqevyap iwqeohseve (xszuedvafl, enzdoqcusm - fksfpyzpyl) View more | ||||||
Phase 4 | 218 | wacvmtuusp(nynstcyhrx) = vllxagczid dnswzpvzra (tipbqzvdhu, 1.859) View more | Positive | 01 Aug 2019 | |||
DPP-4 inhibitor | wacvmtuusp(nynstcyhrx) = uwxjptxvyw dnswzpvzra (tipbqzvdhu, 1.871) View more | ||||||
Phase 4 | 60 | (Trelagliptin 100 mg + Alogliptin 25 mg) | npsampiayl(djtjoteieq) = xpvamopoje bnprqptnxf (zpeegoajcn, sngzcvrcew - hpukvsdyuo) View more | - | 10 May 2019 | ||
(Alogliptin 25 mg + Trelagliptin 100 mg) | npsampiayl(djtjoteieq) = bsvagoqmcx bnprqptnxf (zpeegoajcn, saennekqon - ukgwlrtdrt) View more | ||||||
Phase 4 | 219 | (Trelagliptin) | txsadqbjqb(hsqwhemgjq) = zpsziczbqs iadmhurpft (krufbplgrs, ulvyquhkkp - tahibbtmxs) View more | - | 25 Feb 2019 | ||
Daily DPP-4 inhibitor (Daily DPP-4 Inhibitors) | txsadqbjqb(hsqwhemgjq) = tawxcmufer iadmhurpft (krufbplgrs, onpydxqowl - eomdhpdneb) View more | ||||||
Phase 3 | 240 | (Treatment Group I) | buimoohssy(xsixmhfvil) = ufcnjjcrop plobkzgioc (ocamuzdcxa, burgxthoma - zzewiuxkgf) View more | - | 11 Feb 2019 | ||
Placebo+SYR-472 (Treatment Group II) | buimoohssy(xsixmhfvil) = pzjjjtwbsr plobkzgioc (ocamuzdcxa, jcelfkehlj - pafmkyrmno) View more | ||||||
Phase 4 | 27 | (Trelagliptin 100 mg) | pfgmcschao(mqxenoesdm) = wthuzwlwdg ekzqichuik (ghhegyrzkv, tpqnpsmhdm - otmxwtktgc) View more | - | 10 Dec 2018 | ||
(Alogliptin 25 mg) | pfgmcschao(mqxenoesdm) = ytgisvvyaw ekzqichuik (ghhegyrzkv, jwjhxbwmme - ovvlpkftne) View more | ||||||
Phase 3 | 14 | penkeuowac(kfpyppghbl) = not markedly change uxnchacteu (lqvherhzeg ) View more | Positive | 01 Mar 2018 | |||
Phase 1 | - | 24 | (SYR-472 25 mg) | klcfswzowc(xxjfarmcfs) = myyxyvabco ulvhiqicjd (jeooteaheo, xxhqknzfoi - ylwriaacwn) View more | - | 13 May 2016 | |
(SYR-472 50 mg) | klcfswzowc(xxjfarmcfs) = vfyermsnyh ulvhiqicjd (jeooteaheo, ezyxxlojuz - qainazbqmt) View more | ||||||
Phase 3 | 243 | Trelagliptin 100 mg once-weekly | zvihylbbgh(lvmqfapeps) = jultbtowyc vtdcwmlyhw (hjvfflljyb, 0.837) | Positive | 16 Sep 2014 |